12-11091424-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_176884.2(TAS2R43):c.806T>C(p.Phe269Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_176884.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 18
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000176 AC: 2AN: 1136912Hom.: 1 Cov.: 38 AF XY: 0.00 AC XY: 0AN XY: 570888
GnomAD4 genome Cov.: 18
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.806T>C (p.F269S) alteration is located in exon 1 (coding exon 1) of the TAS2R43 gene. This alteration results from a T to C substitution at nucleotide position 806, causing the phenylalanine (F) at amino acid position 269 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.